Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current WAVE market cap is 810k. The company's latest EPS is CAD -0.0412 and P/E is -0.24.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 1.16M | 1.39M | 1.8M | 1.25M | 412k |
| Operating Income | -1.41M | -697k | -745k | -936k | -2.22M |
| Net Income | -1.21M | -705k | -797k | -664k | -2.22M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 4.39M | 3.49M | 3.68M | 2.69M | 952k |
| Total Liabilities | 1.55M | 1.45M | 1.9M | 1.6M | 2.09M |
| Total Equity | 2.85M | 2.04M | 1.79M | 1.09M | -1.14M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -1.41M | -362k | -799k | -237k | -1.02M |
| Investing | N/A | N/A | N/A | -226k | N/A |
| Financing | N/A | -373k | 222k | 439k | 940k |
| Market Cap | 810k |
| Price to Earnings Ratio | -0.24 |
| Price to Sales Ratio | 1.32 |
| Price to Cash Ratio | 10 |
| Price to Book Ratio | -0.47 |
| Dividend Yield | - |
| Shares Outstanding | 54M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.01 (50%) |
| Company Name | Waverley Pharma Inc |
| Address |
4 - 1250 waverly street winnipeg, manitoba R3T 6C6 |
| Website | https://www.waverleypharma.com |
| Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
